Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compassionate Use Study of Carfilzomib for Patients With Relapsing or Resistant Multiple Myeloma

NCT00999414 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT00999414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00999414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compassionate Use Study of Carfilzomib for Patients With Relapsing or Resistant Multiple Myeloma
Lead sponsor
University of Arkansas
Phase
Expanded access
Overall status
No longer available
Start date
November 30, 2009
Completion date
April 30, 2015
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma